Guardant Health and Patient Advocacy Groups Join Forces to Raise Awareness of the Importance of Complete Biomarker Testing for ...
Incomplete testing fails to meet current medical guideline standards, placing more than 80 percent1 of patients at increased risk of receiving a less effective treatment REDWOOD CITY, Calif., May 05, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: …